dm2treatment
dm2treatment
AI Mind Map
Interactive visualization of lecture concepts
No Mind Map Yet
Generate an AI-powered mind map to visualize lecture concepts
Files & Documents
1 file available for download
Focus
Quiz Questions (33 questions)
1. The development of an autonomic neuropathy confers an increased risk of sudden death.
2. She needs to stop any sulphonylurea drugs she is taking.
3. Less than 10% of caloric intake should be saturated fat.
4. Sodium glucose cotransporter-2 inhibitor is a suitable additional oral antidiabetic agent.
5. Carbohydrate intakes should be 50-55% of total calorie intake.
6. Glucan like peptide -1 agonist are antidiabetic drugs with proved cardiovascular protection.
7. CHO represents 50-60%, Protein 20-30%, Fat 30%, increase the fibers and physical activity.
8. Restrict simple carbohydrates and eat lean meat.
9. Insulin is the suitable additional antidiabetic agent.
10. Sodium glucose cotransporter2 inhibitors are antidiabetic drugs with proved renal safety and protection.
11. She must convert into insulin therapy.
12. CHO represents 50-60%, Protein 20-30%, Fat 30%. increase the fibers and reduce weight Fat represents.
13. Grossly elevated HbA1c levels is suggestive of a starting insulin.
14. Insulin sensitization is the mechanism of action of Biguanides.
15. ATP dependent K⁺ channel is inhibited by Sulphonylureas.
16. Metformin is the most appropriate management approach for his elevated fasting blood glucose levels.
17. Medical nutrition therapy is the treatment of choice.
18. Glycated Hemoglobin HbA1c is the most appropriate test to monitor the glycemic control of a diabetic patient.
19. eGFR < 30 mL/min/1.73 m² is the correct indication to stop metformin therapy in the presence of renal impairment.
20. Insulin is the suitable additional oral antidiabetic agent.
21. Urine analysis is the next investigation needed to know the reason of his condition.
22. SGLT2 Inhibitors are antidiabetic drugs with proven cardiovascular protection.
23. eGFR < 45 mL/minute/1.73 m² is the correct indication to reduce the dose of metformin in the presence of renal impairment.
24. Oral hypoglycaemic agent (Sulphonylureas) is the treatment of choice.
25. First line therapy in type2 DM is not an indication of insulin therapy.
26. Sulphonylureas are Insulin secretagogues.
27. Sulfonylureas are oral antidiabetic drugs with increase in body weigh as side effect.
28. SGLT2I are oral antidiabetic drugs with proved renal protection.
29. False, 90% of patients do not require hypoglycaemic drug therapy in the dietary management of DM.
30. True, Carbohydrate intakes should be 50-55% of total calorie intake in the dietary management of DM.
31. True, Fat intake should not exceed 35% of total calorie intake in the dietary management of DM.
32. False, Ice-cream and chocolates can be consumed in the dietary management of DM.
33. False, In obese patients, calorie intake should not exceed 600 Kcal/day 2 in the dietary management of DM.
Content processed on Dec 27, 2025 11:48 PM
Lecture Summary
📚 AI-Generated Summary
Comprehensive analysis of lecture content
Alright, let's dive into the world of **oral antidiabetic therapy for type 2 Diabetes Mellitus (DM)**. This is really important, so pay close attention. We're going to cover the pathophysiology of **Diabetes**, the old and new antidiabetic drugs, the American Diabetes Association (ADA) 2020 guidelin...
Flashcards
No flashcards created yet
Flashcards help you memorize and review information effectively using spaced repetition
Explore Flashcards